IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 49.74

Change

-0.78 (-1.54)%

Market Cap

N/A

Volume

0.17M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-16 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

+0.56 (+0.40%)

USD 36.67B
FHLC Fidelity® MSCI Health Care In..

+0.35 (+0.52%)

USD 2.62B
FXH First Trust Health Care AlphaD..

+0.50 (+0.47%)

USD 1.07B
XHE SPDR® S&P Health Care Equipme..

+1.22 (+1.34%)

USD 0.21B
IDNA iShares Genomics Immunology an..

-0.02 (-0.09%)

USD 0.12B
SBIO ALPS Medical Breakthroughs ETF

-0.17 (-0.56%)

USD 0.11B
XHS SPDR® S&P Health Care Service..

+0.41 (+0.43%)

USD 0.07B
HTEC Robo Global® Healthcare Techn..

+0.13 (+0.45%)

USD 0.05B
BBP Virtus LifeSci Biotech Product..

+0.19 (+0.32%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

-0.42 (-1.89%)

USD 8.55M

ETFs Containing IHF

MSSS Northern Lights Fund Trus.. 9.38 % 0.00 %

+0.09 (+0.32%)

USD 0.11B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.65% 81% B- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.65% 81% B- 78% C+
Trailing 12 Months  
Capital Gain -4.39% 10% F 21% F
Dividend Return 0.79% 56% F 9% A-
Total Return -3.60% 10% F 18% F
Trailing 5 Years  
Capital Gain 20.71% 48% F 61% D-
Dividend Return 5.06% 63% D 14% F
Total Return 25.77% 52% F 53% F
Average Annual (5 Year Horizon)  
Capital Gain 5.67% 57% F 53% F
Dividend Return 6.30% 62% D 47% F
Total Return 0.64% 63% D 17% F
Risk Return Profile  
Volatility (Standard Deviation) 21.72% 43% F 50% F
Risk Adjusted Return 29.02% 57% F 43% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.